v3.26.1
Revenue
 3 Months Ended
Jun. 30, 2026
Revenue from Contract with Customer [Abstract]  
Revenue

20. REVENUE

Revenue is disaggregated as follows:

 

 

Three months ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2026

 

 

2025

 

Cannabis

 

 

 

 

 

 

Canadian adult-use cannabis1

 

$

29,702

 

 

$

27,021

 

Canadian medical cannabis2

 

 

25,786

 

 

 

21,206

 

International markets cannabis

 

 

9,597

 

 

 

8,755

 

 

 

$

65,085

 

 

$

56,982

 

 

 

 

 

 

 

 

Storz & Bickel

 

$

16,080

 

 

$

15,152

 

 

 

 

 

 

 

 

Net revenue

 

$

81,165

 

 

$

72,134

 

1Canadian adult-use net revenue during the three months ended June 30, 2026 includes excise taxes of $16,203 (three months ended June 30, 2025 – $14,199).

2Canadian medical cannabis net revenue for the three months ended June 30, 2026 includes excise taxes of $2,996 (three months ended June 30, 2025 – $2,415).

The Company recognizes variable consideration related to estimated future product returns and price adjustments as a reduction of the transaction price at the time revenue for the corresponding product sale is recognized. Net revenue reflects actual returns and variable consideration related to estimated returns and price adjustments in the amount of $2,019 for the three months ended June 30, 2026 (three months ended June 30, 2025 – $923). As of June 30, 2026, the liability for estimated returns and price adjustments was $2,097 (March 31, 2026 – $3,638).